Astrid M. Kral

Statistics

Publications

Citations

4.7K

H-Index

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Pennsylvania

Astrid M. Kral is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, enzyme inhibition, and drug discovery.

Publications per year

1990–2017

Publications

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

Katherine M. Call, Tom Glaser, Caryn Y. Ito et al. · Cell · 1990 · 1.9K citations

Life Sciences, Genetics, Molecular Genetics +15

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

Nancy E. Kohl, Charles A. Omer, Michael W. Conner et al. · Nature Medicine · 1995 · 539 citations

Medicine, Cancer Biology, Oncology +11

An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

Jennifer O’Neil, Yair Benita, Igor Feldman et al. · Molecular Cancer Therapeutics · 2016 · 432 citations

Medicine, Oncology, Pharmacology +13

Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors

Stanley F. Barnett, Deborah Defeo-Jones, Sheng Fu et al. · Biochemical Journal · 2005 · 397 citations · Full text

Medicine, Molecular Biology, Pharmacology +14

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Robert B. Lobell, CharlesA. Omer, Marc Abrams et al. · PubMed · 2001 · 239 citations

Medicine, Oncology, Pharmacology +16

1–5 of 28